Arrivo BioVentures
2015
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Early Stage VC
LATEST DEAL TYPE
$49M
LATEST DEAL AMOUNT
3
INVESTORS
Description
Developer of reformulated biopharmaceutical drugs designed to focus on accelerating biologics and small molecules through clinical development. The company's reformulated biopharmaceutical drugs are produced after identifing regulatory strategies to expedite the path to approval through efficient clinical programs, enabling doctors to improve patient lives.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Other Pharmaceuticals and Biotechnology
Primary Office
- Aerial Center Executive Park, 9001 Aerial Center Parkway
- Suite 110
- Morrisville, NC 27560
- United States
+1 (919) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Arrivo BioVentures’s full profile, request a free trial.
Arrivo BioVentures Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | 25-May-2016 | $49M | 0000 | Completed | Startup |
Arrivo BioVentures Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Azur Pharma | Corporation | Minority | 000 0000 | 000000 0 | ||
| Rex Health Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Solas BioVentures | Venture Capital | Minority | 000 0000 | 000000 0 |